CEUFX
Price
$62.68
Change
-$0.26 (-0.41%)
Updated
Nov 19 closing price
Net Assets
132.22B
TIOTX
Price
$17.04
Change
-$0.02 (-0.12%)
Updated
Nov 19 closing price
Net Assets
2.72B
Interact to see
Advertisement

CEUFX vs TIOTX

Header iconCEUFX vs TIOTX Comparison
Open Charts CEUFX vs TIOTXBanner chart's image
American Funds EUPAC 529-F-1
Price$62.68
Change-$0.26 (-0.41%)
VolumeN/A
Net Assets132.22B
Nuveen International Opps Retire
Price$17.04
Change-$0.02 (-0.12%)
VolumeN/A
Net Assets2.72B
CEUFX vs TIOTX Comparison Chart in %
View a ticker or compare two or three
VS
CEUFX vs. TIOTX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEUFX is a Hold and TIOTX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CEUFX has more cash in the bank: 132B vs. TIOTX (2.72B). TIOTX pays higher dividends than CEUFX: TIOTX (0.99) vs CEUFX (0.76). CEUFX was incepted earlier than TIOTX: CEUFX (23 years) vs TIOTX (13 years). CEUFX (0.91) is less costly to investors than TIOTX (0.85). CEUFX is a more actively managed with annual turnover of: 35.00 vs. TIOTX (21.00). TIOTX has a lower initial minimum investment than CEUFX: TIOTX (0) vs CEUFX (250). TIOTX annual gain was more profitable for investors over the last year : 14.27 vs. CEUFX (13.09). CEUFX return over 5 years is better than : 5.68 vs. TIOTX (2.10).
CEUFXTIOTXCEUFX / TIOTX
Total Expense Ratio0.910.85107%
Annual Report Gross Expense Ratio0.910.85107%
Fund Existence23 years13 years-
Gain YTD18.82516.689113%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets132B2.72B4,860%
Annual Yield % from dividends0.760.9977%
Returns for 1 year13.0914.2792%
Returns for 3 years33.1931.59105%
Returns for 5 years5.682.10271%
Returns for 10 years50.7071.6471%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NYVTX27.430.03
+0.11%
Davis NY Venture A
LMNOX50.65N/A
N/A
Patient Opportunity I
SWSCX20.91N/A
N/A
Schwab Small-Cap Equity
SVXCX67.07N/A
N/A
Smead International Value C
FSQZX11.22N/A
N/A
Fidelity Advisor Sustainable Intl Eq Z